Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Pain, Postoperative 3Colonic Neoplasms 3Esophageal Neoplasms 2Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Nutrition Disorders 1Melanoma 1Liver Neoplasms 1Liver Diseases 1Insulin Resistance 1Ileus 1Glioblastoma 1Gastroparesis 1Feeding and Eating Disorders 1Esophageal Squamous Cell Carcinoma 1Dumping Syndrome 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Agnosia 1Adenocarcinoma 1

Interventions

Bevacizumab 6Nivolumab 5pembrolizumab 4Gemcitabine 4Cisplatin 3regorafenib 2fludarabine 2Sorafenib 2Paclitaxel 2Oxaliplatin 2Leucovorin 2Irinotecan 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Azacitidine 2vocimagene amiretrorepvec 1ulixertinib 1temsirolimus 1spartalizumab 1sonidegib 1selinexor 1sargramostim 1sacituzumab govitecan 1ruxolitinib 1rucaparib 1pazopanib 1olutasidenib 1olaparib 1motexafin gadolinium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Acetaminophen × Gastrointestinal × Clear all
NCT01607905 2023-01-26

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Karyopharm Therapeutics Inc

Phase 1 Completed
192 enrolled 29 charts
CNSDermatologicGastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Glioblastoma, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡